Results

Partnerships: Adopt-A-Genome
… work with undergraduates in the analysis and publication of the claimed genome sequences. This opportunity, provided by the Department of Energy Joint Genome Institute, builds upon thousands of … while nurturing a fresh cohort of users Reach the next generation of genome scientists and recruit new talent for …
Learn more
Sequence‐Based Introgression Mapping Identifies Candidate White Mold Tolerance Genes in Common Bean
Learn more
Multiple Origins and Rapid Evolution of Duplicated Mitochondrial Genes in Parthenogenetic Geckos (Heteronotia binoei; Squamata, Gekkonidae)
Learn more
Isolation and sequencing of a single copy of an introgressed chromosome from a complex genome for gene and SNP identification
Learn more
Association mapping, transcriptomics, and transient expression identify candidate genes mediating plant–pathogen interactions in a tree
Learn more
Microsatellite discovery from BAC end sequences and genetic mapping to anchor the soybean physical and genetic maps
Learn more
Fine Mapping of the Bsr1 Barley Stripe Mosaic Virus Resistance Gene in the Model Grass Brachypodium distachyon
Learn more
Genome‐wide mapping of cytosine methylation revealed dynamic DNA methylation patterns associated with genes and centromeres in rice
Learn more
Mapping the microbiome milieu
Learn more
Enlarging Windows into Understanding Gene Functions
JGI innovates protocol revealing how genetic variations in sequences affect traits. In a text file, the rows of letters A, T, C and G appearing over and over in a … to conduct comparative analyses across the genomes of multiple species in a single experiment. “Effectively, you …
Learn more
Genome sequencing provides insight into the reproductive biology, nutritional mode and ploidy of the fern pathogen Mixia osmundae
Learn more
Natural Prodcast Episode 19: Bill Fenical
… for you here today. We got the opportunity to talk to one of the real legends of natural products, Professor Bill … the most effective application, of marine molecules in general. DAN UDWARY: Maybe can you explain to our audience … by Bristol Myers Squibb. And it is now in phase III in multiple sites, phase III human clinical trials. ALISON …
Learn more